Ambu on EU bronchoscope approval: Makes us the most wide-ranging and dominant player on the market

Wednesday's CE mark authorization for Ambu's latest bronchoscope and attached sampling system will have a positive effect on the company's total endoscopy sales, and the green light itself shows that they are the most innovative player, the firm says.

Photo: Ambu/PR

Competition has been heating up on the market for pulmonary endoscopes, also called bronchoscopes, where Ambu's product Ascope has been very successful.

Boston Scientific, Pentax, Olympus and Verathon have all thrown their hats into the ring, and Chinese copycats are emerging.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs